GO:0004832 | valine-tRNA ligase activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0033688 | regulation of osteoblast proliferation | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0001649 | osteoblast differentiation | 2.45e-03 | 1.00e+00 | 4.722 | 2 | 5 | 74 |
GO:0042582 | azurophil granule | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0034773 | histone H4-K20 trimethylation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0036089 | cleavage furrow formation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 4 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 5 |
GO:0043931 | ossification involved in bone maturation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 3 | 6 |
GO:0043297 | apical junction assembly | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 6 |
GO:0006903 | vesicle targeting | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0042581 | specific granule | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 7.16e-03 | 1.00e+00 | 3.931 | 2 | 15 | 128 |
GO:0090307 | spindle assembly involved in mitosis | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 8 |
GO:0043296 | apical junction complex | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0071354 | cellular response to interleukin-6 | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 4 | 11 |
GO:0008380 | RNA splicing | 1.17e-02 | 1.00e+00 | 3.565 | 2 | 21 | 165 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 12 |
GO:0061025 | membrane fusion | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 13 |
GO:0050772 | positive regulation of axonogenesis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 14 |
GO:0010467 | gene expression | 1.47e-02 | 1.00e+00 | 2.453 | 3 | 49 | 535 |
GO:0000188 | inactivation of MAPK activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 15 |
GO:0032467 | positive regulation of cytokinesis | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 16 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 20 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 6 | 24 |
GO:0051496 | positive regulation of stress fiber assembly | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 4 | 27 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 6 | 29 |
GO:0032154 | cleavage furrow | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 30 |
GO:0005925 | focal adhesion | 3.21e-02 | 1.00e+00 | 2.792 | 2 | 14 | 282 |
GO:0006892 | post-Golgi vesicle-mediated transport | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 32 |
GO:0021762 | substantia nigra development | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 35 |
GO:0030334 | regulation of cell migration | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 36 |
GO:0006396 | RNA processing | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 6 | 40 |
GO:0006887 | exocytosis | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 1 | 44 |
GO:0032481 | positive regulation of type I interferon production | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 48 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 5.30e-02 | 1.00e+00 | 4.204 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 5.30e-02 | 1.00e+00 | 4.204 | 1 | 3 | 53 |
GO:0005654 | nucleoplasm | 5.35e-02 | 1.00e+00 | 1.742 | 3 | 68 | 876 |
GO:0042826 | histone deacetylase binding | 5.79e-02 | 1.00e+00 | 4.073 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 6.08e-02 | 1.00e+00 | 4.001 | 1 | 5 | 61 |
GO:0003677 | DNA binding | 6.50e-02 | 1.00e+00 | 1.629 | 3 | 52 | 947 |
GO:0016032 | viral process | 6.83e-02 | 1.00e+00 | 2.190 | 2 | 30 | 428 |
GO:0030308 | negative regulation of cell growth | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 3 | 70 |
GO:0030496 | midbody | 7.23e-02 | 1.00e+00 | 3.742 | 1 | 6 | 73 |
GO:0005515 | protein binding | 7.32e-02 | 1.00e+00 | 0.729 | 7 | 198 | 4124 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 7.52e-02 | 1.00e+00 | 3.684 | 1 | 2 | 76 |
GO:0005634 | nucleus | 7.55e-02 | 1.00e+00 | 0.852 | 6 | 158 | 3246 |
GO:0005938 | cell cortex | 7.61e-02 | 1.00e+00 | 3.665 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 8.09e-02 | 1.00e+00 | 3.574 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 8.19e-02 | 1.00e+00 | 3.556 | 1 | 2 | 83 |
GO:0045202 | synapse | 8.19e-02 | 1.00e+00 | 3.556 | 1 | 3 | 83 |
GO:0030027 | lamellipodium | 8.66e-02 | 1.00e+00 | 3.472 | 1 | 3 | 88 |
GO:0061024 | membrane organization | 8.75e-02 | 1.00e+00 | 3.456 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 8.85e-02 | 1.00e+00 | 3.440 | 1 | 4 | 90 |
GO:0005737 | cytoplasm | 1.03e-01 | 1.00e+00 | 0.891 | 5 | 127 | 2633 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 2 | 108 |
GO:0042981 | regulation of apoptotic process | 1.09e-01 | 1.00e+00 | 3.124 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.10e-01 | 1.00e+00 | 3.111 | 1 | 6 | 113 |
GO:0007049 | cell cycle | 1.12e-01 | 1.00e+00 | 3.086 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 7 | 119 |
GO:0006184 | GTP catabolic process | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 7 | 130 |
GO:0007165 | signal transduction | 1.28e-01 | 1.00e+00 | 1.660 | 2 | 24 | 618 |
GO:0030168 | platelet activation | 1.35e-01 | 1.00e+00 | 2.792 | 1 | 5 | 141 |
GO:0044212 | transcription regulatory region DNA binding | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 13 | 143 |
GO:0005739 | mitochondrion | 1.43e-01 | 1.00e+00 | 1.567 | 2 | 32 | 659 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.53e-01 | 1.00e+00 | 2.601 | 1 | 18 | 161 |
GO:0006355 | regulation of transcription, DNA-templated | 1.63e-01 | 1.00e+00 | 1.450 | 2 | 31 | 715 |
GO:0007264 | small GTPase mediated signal transduction | 1.65e-01 | 1.00e+00 | 2.489 | 1 | 8 | 174 |
GO:0005575 | cellular_component | 1.76e-01 | 1.00e+00 | 2.385 | 1 | 4 | 187 |
GO:0005856 | cytoskeleton | 1.78e-01 | 1.00e+00 | 2.362 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 12 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.86e-01 | 1.00e+00 | 2.295 | 1 | 8 | 199 |
GO:0015031 | protein transport | 1.90e-01 | 1.00e+00 | 2.266 | 1 | 10 | 203 |
GO:0006281 | DNA repair | 1.90e-01 | 1.00e+00 | 2.266 | 1 | 24 | 203 |
GO:0044822 | poly(A) RNA binding | 1.95e-01 | 1.00e+00 | 1.289 | 2 | 45 | 799 |
GO:0019899 | enzyme binding | 1.95e-01 | 1.00e+00 | 2.217 | 1 | 7 | 210 |
GO:0030054 | cell junction | 2.02e-01 | 1.00e+00 | 2.163 | 1 | 5 | 218 |
GO:0007411 | axon guidance | 2.18e-01 | 1.00e+00 | 2.043 | 1 | 8 | 237 |
GO:0008283 | cell proliferation | 2.20e-01 | 1.00e+00 | 2.031 | 1 | 8 | 239 |
GO:0003723 | RNA binding | 2.26e-01 | 1.00e+00 | 1.983 | 1 | 22 | 247 |
GO:0070062 | extracellular vesicular exosome | 2.29e-01 | 1.00e+00 | 0.836 | 3 | 51 | 1641 |
GO:0005524 | ATP binding | 2.31e-01 | 1.00e+00 | 1.131 | 2 | 37 | 892 |
GO:0008150 | biological_process | 2.45e-01 | 1.00e+00 | 1.855 | 1 | 3 | 270 |
GO:0008285 | negative regulation of cell proliferation | 2.50e-01 | 1.00e+00 | 1.818 | 1 | 11 | 277 |
GO:0009986 | cell surface | 2.61e-01 | 1.00e+00 | 1.747 | 1 | 5 | 291 |
GO:0003674 | molecular_function | 2.66e-01 | 1.00e+00 | 1.717 | 1 | 4 | 297 |
GO:0005829 | cytosol | 2.72e-01 | 1.00e+00 | 0.713 | 3 | 88 | 1787 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.81e-01 | 1.00e+00 | 1.623 | 1 | 17 | 317 |
GO:0007596 | blood coagulation | 2.98e-01 | 1.00e+00 | 1.526 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.99e-01 | 1.00e+00 | 1.518 | 1 | 23 | 341 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.26e-01 | 1.00e+00 | 1.373 | 1 | 21 | 377 |
GO:0016020 | membrane | 3.56e-01 | 1.00e+00 | 0.694 | 2 | 56 | 1207 |
GO:0045087 | innate immune response | 3.78e-01 | 1.00e+00 | 1.111 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.80e-01 | 1.00e+00 | 1.099 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 4.55e-01 | 1.00e+00 | 0.764 | 1 | 8 | 575 |
GO:0005886 | plasma membrane | 5.70e-01 | 1.00e+00 | 0.131 | 2 | 46 | 1784 |
GO:0006351 | transcription, DNA-templated | 6.89e-01 | 1.00e+00 | -0.140 | 1 | 47 | 1076 |
GO:0005730 | nucleolus | 7.36e-01 | 1.00e+00 | -0.318 | 1 | 74 | 1217 |